Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis.

@article{Gupta2015EfficacyAS,
  title={Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis.},
  author={Sandeep Kumar Gupta and Joanne M Vitanza and Margaret H. Collins},
  journal={Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association},
  year={2015},
  volume={13 1},
  pages={66-76.e3}
}
BACKGROUND & AIMS No treatment has been approved by the U.S. Food and Drug Administration for eosinophilic esophagitis (EoE). We investigated the efficacy and safety of a new formulation of oral budesonide suspension (OBS), a corticosteroid, in a prospective, placebo-controlled, dose-ranging study. METHODS Subjects 2-18 years old with symptoms of EoE and peak eosinophil counts ≥20/high-power field at ≥2 levels of the esophagus were randomly assigned to groups given placebo or low-dose, medium… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS
40 Citations
22 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

and Drug Administration Guidance for Industry

  • US Foo
  • Patient-reported outcome measures: use in medical…
  • 2013

Similar Papers

Loading similar papers…